annb0t
Top 20
Immutep Limited
SYDNEY, AUSTRALIA, May 20, 2022 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutepâ or âthe Companyâ), a biotechnology company developing novel LAG-3 related immunotherapy treatments for cancer and autoimmune diseases, announces Immutep has been invited to present at investor conferences, as outlined below.
Wilsons Rapid Insightsâ 26 May 2022
Presenter: Marc Voigt, CEO and Deanne Miller, COO of Immutep
Presentation time & date: All day...
>>> Read more: Immutep to Present at Investor Conferences
SYDNEY, AUSTRALIA, May 20, 2022 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutepâ or âthe Companyâ), a biotechnology company developing novel LAG-3 related immunotherapy treatments for cancer and autoimmune diseases, announces Immutep has been invited to present at investor conferences, as outlined below.
Wilsons Rapid Insightsâ 26 May 2022
Presenter: Marc Voigt, CEO and Deanne Miller, COO of Immutep
Presentation time & date: All day...
>>> Read more: Immutep to Present at Investor Conferences
